ITGAM and central nervous system cancer: The issue of cell heterogeneity and functional phenotypes of GAMs (isolated as CD11b+ cells from clinical GBM samples or experimental murine gliomas) and analyzed using bulk transcriptomics have been addressed in many studies, but demonstrated conflicting results [38].